Web Results

Merck KGaA's lung cancer drugs show promise in early-stage trials

feeds.reuters.com

FRANKFURT (Reuters) - Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients,

Congo receives first doses of Ebola vaccine amid outbreak

feeds.reuters.com

GENEVA/KINSHASA (Reuters) - The first batch of 4, 000 experimental Ebola vaccines to combat an outbreak suspected of killing 23 people arrived in Cong

Walgreen, Kroger, Albertsons, HEB sue Allergan over dry-eye drug

feeds.reuters.com

NEW YORK (Reuters) - Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to

Roche breast cancer drug treatment time can be halved - study

feeds.reuters.com

(Reuters) - Treating early stage breast cancer patients for just six months with Roche's Herceptin works as well as the current 12-month regimen, res

Common cancer treatment works better on men than women: study

globalnews.ca

A first-line treatment for some cancers seems to have a greater effect on men than women, according to a new study, though researchers aren't sure w

New peanut allergy test is safer and more accurate, researchers say

globalnews.ca

British researchers have devised a new way to test for peanut allergies that could be more effective than what's done now.

FDA chief questions protections on drug rebates, stocks fall

feeds.reuters.com

(Reuters) - U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers s

Surgeons' skills improve with age

feeds.reuters.com

(Reuters Health) - Surgeons' skills may improve with age, and male and female surgeons perform equally well, a recent U.S. study finds.

Sivantos owner EQT forges $8 billion hearing aid deal

feeds.reuters.com

COPENHAGEN/FRANKFURT (Reuters) - Hearing aid makers Widex and Sivantos agreed to merge on Wednesday to form the world's third-largest supplier behind

U.S. state lawsuits against Purdue Pharma over opioid epidemic mount

feeds.reuters.com

NEW YORK (Reuters) - Litigation against OxyContin maker Purdue Pharma LP is intensifying as six more U.S. states on Tuesday announced lawsuits, accus